AR106393A2 - USE OF THE CHLORIDE CHANNEL OPENER TO PREPARE A PHARMACEUTICAL COMPOUND TO TREAT ABDOMINAL DISEASE - Google Patents

USE OF THE CHLORIDE CHANNEL OPENER TO PREPARE A PHARMACEUTICAL COMPOUND TO TREAT ABDOMINAL DISEASE

Info

Publication number
AR106393A2
AR106393A2 ARP160103175A ARP160103175A AR106393A2 AR 106393 A2 AR106393 A2 AR 106393A2 AR P160103175 A ARP160103175 A AR P160103175A AR P160103175 A ARP160103175 A AR P160103175A AR 106393 A2 AR106393 A2 AR 106393A2
Authority
AR
Argentina
Prior art keywords
chloride channel
channel opener
prepare
pharmaceutical compound
abdominal disease
Prior art date
Application number
ARP160103175A
Other languages
Spanish (es)
Inventor
Kuno Sachiko
Ueno Ryuji
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of AR106393A2 publication Critical patent/AR106393A2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describe un uso de un abridor de canal de cloruro, en especial un compuesto de prostaglandina, para el tratamiento de malestar abdominal. También se describe un uso de un abridor del canal de cloruro, en especial un compuesto de prostaglandina, para el tratamiento de trastornos gastrointestinales funcionales.A use of a chloride channel opener, especially a prostaglandin compound, for the treatment of abdominal discomfort is described. A use of a chloride channel opener, especially a prostaglandin compound, for the treatment of functional gastrointestinal disorders is also described.

ARP160103175A 2002-12-27 2016-10-18 USE OF THE CHLORIDE CHANNEL OPENER TO PREPARE A PHARMACEUTICAL COMPOUND TO TREAT ABDOMINAL DISEASE AR106393A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43646202P 2002-12-27 2002-12-27

Publications (1)

Publication Number Publication Date
AR106393A2 true AR106393A2 (en) 2018-01-10

Family

ID=61158577

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP160103175A AR106393A2 (en) 2002-12-27 2016-10-18 USE OF THE CHLORIDE CHANNEL OPENER TO PREPARE A PHARMACEUTICAL COMPOUND TO TREAT ABDOMINAL DISEASE

Country Status (1)

Country Link
AR (1) AR106393A2 (en)

Similar Documents

Publication Publication Date Title
NO20053623L (en) Derivatives of prostaglandins for the treatment of abdominal discomfort
CY1112067T1 (en) USE OF FLIBANSERINE FOR THE TREATMENT OF PRE-MONOPOLY DISORDERS
CY1111797T1 (en) LOCAL PHARMACEUTICAL FORM FOR IVERMECTIN FOR DERMATOLOGICAL TREATMENT
ECSP045069A (en) USE OF FLIBANSERINE IN THE TREATMENT OF SEXUAL DISORDERS
EA200800538A1 (en) THERAPEUTIC CONNECTIONS
EA200870360A1 (en) BENZIMIDAZOLY, possessing activity in relation to M1 receptors, and their use in medicine
UY28473A1 (en) NEW COMPOUNDS
EA200701175A1 (en) MEDICINES INTENDED FOR THE TREATMENT OR PREVENTION OF FIBROUS DISEASES
IS2517B (en) Use of substituted 2-aminotetralins in the prevention of Parkinson's disease
NO20053042L (en) Use of spongosine (2-methoxyadenosine) for the treatment of pain, especially hyperalgesia.
EA200700493A1 (en) NEW APPLICATION OF PEPTIDE COMPOUNDS FOR THE TREATMENT OF PATIENTS WITH BONE CANCER, AND ALSO PAIN CAUSED BY CHEMOTHERAPY AND NUCLEOSID
EA200700909A1 (en) AZAINDOLKARBOXAMIDES
DK1694318T3 (en) (S) -2-N-propylamino-5-hydroxytetraline as D3 agonist therapeutic
BRPI0412893A (en) compound, pharmaceutical composition, use of a compound, and methods for preventing, treating or ameliorating inflammatory diseases or conditions, or ophthalmic diseases or conditions, treating or ameliorating cancer, and for producing a compound
ECSP034810A (en) DERETADOS HETEROCICLILALCOXI-, -ALQUILTIO- Y - ALQUILAMINOBENZAZOL SUCH AS LIGANDOS 5-HIDROXITRIPTAMINA-6
BRPI0408063A (en) methods and compositions involving mda-7
EE200200107A (en) Use of a fast-acting selective serotonin reuptake inhibitor in the manufacture of a medicament for the treatment of sexual dysfunction
DE602004008658D1 (en) TREATMENT OF NEURODEGENERATIVE DISEASES
SE0101082D0 (en) Novel use
ATE374195T1 (en) INDAZOL-3-ONE AND ANALOGUES AND DERIVATIVES THEREOF THAT MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1).
AR106393A2 (en) USE OF THE CHLORIDE CHANNEL OPENER TO PREPARE A PHARMACEUTICAL COMPOUND TO TREAT ABDOMINAL DISEASE
GEP201606538B (en) Preoperative treatment of post operative pain
SE0200198D0 (en) New use
EA200601514A1 (en) DERIVATIVES OF PIPERASINUM URINE FOR THE TREATMENT OF ENDOMETRIOSIS
HUP0301276A2 (en) Combination therapy for the treatment of estrogen-sensitive disease

Legal Events

Date Code Title Description
FC Refusal